Full Text
HTA197 What Drives the Limited Scope of French National Authority for Health (HAS) Economic Opinions for Rare Diseases in France?

Abstract

Authors

J Carette A Ben Haddada M Massetti

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×